CTTC

Calmare Therapeutics Inc.

 
Common Stock SEC Reporting - Delinquent
OTCQB
Verified Company Profile 11/30/2016
Contact Info
  • 1375 Kings Highway East
  • Fairfield, CT 06824

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0000102198
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 1968
Employees 8 a/o Nov 29, 2016
Company Officers/Contacts
Conrad Mir CEO, President
Christine Chansky, M.D., J.D. Officer
Thomas Richtarich CFO
Stephen J. D'Amato, M.D. Chief Med. Officer
Seth A. Brookman Legal Counsel
Carl O'Connell Advisor
Janet Vasquez Public Relations
Company Directors
Peter Brennan Chairman
Rustin Howard
Conrad Mir
Carl O'Connell
Robert Conway, Jr., USN Ret
Stephen Roehrich, USN Ret.
Stan Yarbro
Company Notes
  • Formerly=Competitive Technologies, Inc. until 6-2015
  • Formerly=University Patents, Inc. until 12-94
Service Providers
Accounting/Auditing Firm
Mayer Hoffman McCann CPAs
The New York Practice of Mayer Hoffman McCann P.C.
1065 Avenue of the Americas
New York, NY, 10018
United States

Legal Counsel
Lucosky Brookman LLP
101 Wood Avenue South
5th Floor
Woodbridge, NJ, 08830
United States

Investor Relations Firm
JV Public Relations
99 Madison Avenue
Suite 5001
New york, NY, 10016
United States

CTTC Security Details
Share Structure
Market Value1 $5,750,081 a/o Dec 09, 2016
Authorized Shares 100,000,000 a/o Oct 07, 2016
Outstanding Shares 28,787,831 a/o Oct 07, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 22,315,092 a/o Oct 07, 2016
Par Value No Par Value
Shareholders
Shareholders of Record 439 a/o Oct 07, 2016
Short Selling Data
Short Interest 5,475 (3,782.98%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security